Life Sciences Market Research Reports & Industry Analysis

Publications found: 511,943
Sort by:

Quotient Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Quotient Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aratana Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aratana Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cellular Biomedicine Group, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cellular Biomedicine Group, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cerecor Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cerecor Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Natera Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Natera Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Theravance Biopharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Theravance Biopharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Blueprint Medicines Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Blueprint Medicines Corp Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

GlycoMimetics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

GlycoMimetics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Millendo Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Millendo Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bioverativ Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioverativ Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Molecular Templates Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Molecular Templates Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cara Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cara Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Seres Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Seres Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Kalvista Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Kalvista Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Stemline Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Stemline Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tetraphase Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tetraphase Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

VBI Vaccines Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

VBI Vaccines Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Checkpoint Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Checkpoint Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Intellia Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Intellia Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aralez Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aralez Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

MacroGenics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MacroGenics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NewLink Genetics Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NewLink Genetics Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TherapeuticsMD Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TherapeuticsMD Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Five Prime Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Five Prime Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Endocyte Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Endocyte Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pacira BioSciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pacira BioSciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sarepta Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sarepta Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

K2M Group Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

K2M Group Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Merus BV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Merus BV Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Myos Rens Technology Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Myos Rens Technology Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Portola Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Portola Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BOD Australia Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BOD Australia Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Dimerix Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Dimerix Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Noxopharm Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Noxopharm Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vectus Biosystems Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vectus Biosystems Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Paradigm Biopharmaceuticals Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Paradigm Biopharmaceuticals Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ultracharge Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ultracharge Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Black Star Petroleum Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Black Star Petroleum Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sienna Cancer Diagnostics Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sienna Cancer Diagnostics Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Zelda Therapeutics Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Zelda Therapeutics Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Amplia Therapeutics Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Amplia Therapeutics Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Race Oncology Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Race Oncology Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Stemcell United Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Stemcell United Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Manalto Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Manalto Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Regeneus Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regeneus Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Invion Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Invion Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bioxyne Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioxyne Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Smart Marine Systems Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Smart Marine Systems Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

MGC Pharmaceuticals Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MGC Pharmaceuticals Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tempo Australia Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tempo Australia Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

282,300
1,254
130
193
402
67
112
212
39
268
170
192
671
866
1,214
153
34
504
109
299
61
384
2,654
1,548
553
205
69
490
372
241
217
199
160
159
115
114
80
79
62
51
38
12
93
146
896
201
142
184
177
386
284
506
57
186
1,762
64,306
14,910
12,134
1,332
926
740
1,080
2,344
222
52
704
151
1,273
225
1,265
433
337
3,434
2,697
1,799
428
1,542
42,070
345
1,037
1,252
3,983
1,323
6,939
85
72
5,113
254
2,856
490
210
2,255
578
1,120
1,850
4,362
2,373
99
1,567
17,119
185

Publishers

3,720
3,041
2,879
251
95
1
799
698
53
4
101,258
3,799
444
210
78,127
1,866
3,776
35
37
202
75
5,253
3,557
10
946
120
123
238
76,468
3,892
68
8,201
2
2,258
21,664
1,891
79
68
703
106
16,437
1
6,889
30,350
501
5,847
1
3
268
1
1
7
4,898
450
142
1
2,189
1
136
9
1,696
8
29
79
8
75
753
11,499
171
321
1
66
5
214
458
56
32,488
3
4
536
197
3
149
74
802
1,261
218
29
5
44
173
124
558
33
159
348
110
186
1,413
393
4
53
61
20
137
111
2
3,749
18
221
330
392
332
51
48,557
140
43
212
3,035
221
689
1,244
389
205
323
37
1,459
7

Regions

379
312
244
244
238
234
231
213
212
212
210
210
208
198
197
183
155
154
152
149
143
141
140
140
139
139
136
136
131
126
115
115
47
43
18
15
14
13
13
13
11
9
8
6
6
5
5
5
4
3
3
3
3
3
3
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1,771
1,559
1,488
1,488
1,384
1,381
665
578
439
383
354
346
311
310
309
308
306
306
303
300
284
281
281
280
275
272
272
270
268
265
264
264
262
261
256
237
233
230
224
219
213
198
169
168
167
167
159
159
153
132
61
32
31
25
14
2,014
634
286
268
1,928
2
134
131
3,238
641
313
208
464,740
194
301
285
275
265
247
236
1,387
1,055
5,487

Price

—

Date

—

Pages

—

Offers

1
391
7
5